CommercialPrior AuthLow impact
08.01.54d, Emapalumab-lzsg (Gamifant®)
Independence Blue Cross·Oncology, Hematology, Rheumatology·Pharmacy
Effective date
Jul 28, 2025
We identified it
Jun 19, 2026
Summary
Insurance company updated medical necessity criteria and medical coding requirements for Emapalumab-lzsg (Gamifant®), a specialty pharmacy drug. This affects billing and prior authorization requirements for this specific medication.
Action Required
By July 28, 2025: Billing team and providers should review updated medical necessity criteria for Emapalumab-lzsg (Gamifant®) prescriptions. Update prior authorization processes and documentation requirements in billing system. Ensure medical coding compliance for this specialty drug to prevent claim denials.